Please try another search
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
| Name | Age | Since | Title |
|---|---|---|---|
| Joseph C. Sardano | 69 | 2010 | Co-Founder, Chairman & CEO |
| Gary D. Monheit | - | - | Member of Medical Advisory Board |
| Armand B. Cognetta | - | 2011 | Chairman of Medical Advisory Board |
| Angela M. Abbatecola | - | - | Member of Medical Advisory Board |
| Samuel O'Rear | 75 | 2012 | Independent Director |
| John P. Heinrich | 76 | 2012 | Independent Director |
| Robert E. Beer | - | 2017 | Member of Medical Advisory Board |
| William H. McCall | 77 | 2015 | Independent Director |
| David J. Goldberg | - | 2017 | Member of Medical Advisory Board |
| Michael J. Sardano | 35 | 2017 | President, General Counsel, Corporate Secretary & Director |
| Brian Berman | - | 2017 | Member of Medical Advisory Board |
| Michael H. Gold | - | - | Member of the Medical Advisory Board |
| Kenrick Anthony Spence | - | - | Member of Medical Advisory Board |
| Anthony Benedict Petrelli | 70 | 2016 | Independent Director |
| Megan Cornish | 38 | 2021 | Independent Director |
| William I. Roth | - | - | Member of Medical Advisory Board |
| Kevin L. Schewe | 67 | 2017 | Member of Medical Advisory Board |
| Mark S. Nestor | - | 2013 | Medical Director & Member of Medical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
